-

10:17:29 PM

NNMX Stock News

NNMX - Nanomix Corp

11/29/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into a distribution agreement with Gepa Srl (“Gepa”), a

RHEA-AI

neutral

11/09/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into an exclusive distribution agreement with Woodley

RHEA-AI

neutral

11/04/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into a multi-region distribution agreement with Mast Group

RHEA-AI

neutral

10/20/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced a new distribution agreement with Diaclinic SpA (“Diaclinic”), a medical

RHEA-AI

neutral

09/12/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has entered into a distribution agreement with IPS Genomix s.a.l. (“IPS”),

RHEA-AI

neutral

09/02/22 8:30 AM

OTC : NNMX

covid-19low float

Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable,

RHEA-AI

neutral

08/31/22 9:00 AM

OTC : NNMX

managementlow float

Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced the appointment of Tadd S. Lazarus, M.D., to the Board of Directors as an

RHEA-AI

neutral

08/23/22 8:30 AM

OTC : NNMX

low float

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with BIOASIA PTE LTD in Singapore

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has entered into a distribution agreement with BIOASIA PTE LTD (“Bioasia”),

RHEA-AI

neutral

08/18/22 8:30 AM

OTC : NNMX

low float

Nanomix Announces ISO 13485:2016 Certification for its New Facility in San Leandro, CA

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced that it has received ISO 13485:2016 certification for its new facility in San Leandro, California.

RHEA-AI

neutral

07/26/22 9:30 AM

OTC : NNMX

managementlow float

Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced the appointment of Dr. Thomas Schlumpberger as Chief Executive Officer and as a member of the Board of

RHEA-AI

very positive